Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Benfield

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Drugs|May 1, 1996
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery diseaseR N Brogden, P Benfield
Drugs|February 1, 1988
Sulconazole. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesP Benfield, S P Clissold
Drugs|February 1, 1990
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic useP A Todd, P Benfield
Arzneimittel-Forschung|January 1, 1983
Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the ratD P Benfield, D K Luscombe
Drugs|February 17, 1998
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disordersN S Gunasekara, S Noble, P Benfield
Pharmacoeconomics|December 9, 1992
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of lifeR Whittington, L B Barradell, P Benfield
Drugs|October 1, 1996
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosisH M Bryson, B Fulton, P Benfield
Pharmacoeconomics|January 8, 1993
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugsL B Barradell, R Whittington, P Benfield
Drugs|July 1, 1995
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain managementJ C Gillis, P Benfield, K L Goa
Pharmacoeconomics|May 27, 1999
Fosphenytoin. Pharmacoeconomic implications of therapyS M Holliday, P Benfield, G L Plosker
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Drugs|May 1, 1996
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery diseaseR N Brogden, P Benfield
Drugs|February 1, 1988
Sulconazole. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesP Benfield, S P Clissold
Drugs|February 1, 1990
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic useP A Todd, P Benfield
Arzneimittel-Forschung|January 1, 1983
Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the ratD P Benfield, D K Luscombe
Drugs|February 17, 1998
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disordersN S Gunasekara, S Noble, P Benfield
Pharmacoeconomics|December 9, 1992
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of lifeR Whittington, L B Barradell, P Benfield
Drugs|October 1, 1996
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosisH M Bryson, B Fulton, P Benfield
Pharmacoeconomics|January 8, 1993
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugsL B Barradell, R Whittington, P Benfield
Drugs|July 1, 1995
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain managementJ C Gillis, P Benfield, K L Goa
Pharmacoeconomics|May 27, 1999
Fosphenytoin. Pharmacoeconomic implications of therapyS M Holliday, P Benfield, G L Plosker
Pageof 9